Actinium-225-macropa-pelgifatamab | Interleukin Related interleukin-related.com

Product Name :
Actinium-225-macropa-pelgifatamab

Search keywords :
Macropa

drugId :
null

Target Vo:
Prostate-Specific Membrane Antigen

Target Vo Short Name :
PSMA

Moa_Name:
Ionising radiation emitters

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :
Bayer AG

Active Indication_Name:
Prostatic Neoplasms, Castration-Resistant

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H3 (acetyl K14) Antibody
PDCD4 Antibody
KLF4 Antibody: KLF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to KLF4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts